RONALD TYNES: Open Payments
NPI 1033450333 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 23 payments from 10 companies in 2025. Trend: 2023 $791 · 2024 $550 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $57 |
| Abbott Laboratories | 3 | $45 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| PFIZER INC. | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
Products named: Kerendia, LEQVIO, LifeVest, CONFIRM RX, INSPIRE, ENTRESTO, ELIQUIS, FUROSCIX.
Industry payments across MS — which companies pay providers there.
